FABP3 and dementia: Notably, higher FABP3 levels are observed in patients with dementia with Lewy bodies than in Parkinson’s disease dementia and Alzheimer’s disease, indicating the potential of FABP3 as a biomarker distinctive to dementia with Lewy bodies.